Investor Overview At Gilead we are inspired by the opportunity to address unmet medical needs for patients living with life-threatening diseases around the world. Stock Quote Stock Quote Volume: Aug 9, 2021 9:37 AM EDT Latest News August 5, 2021 Kite and Appia Bio Announce Collaboration to Research and Develop Allogeneic Cell Therapies for Cancer August 4, 2021 BioNTech Completes Acquisition of Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, Maryland August 3, 2021 Gilead Sciences Endows Its Foundation With More Than $200 Million to Support Health Justice, Community Giving and Employee Match Program View All Events Jul 29, 2021 at 4:30 PM EDT Second Quarter 2021 Gilead Sciences Earnings Conference Call Q2 2021 Earnings Release 435.9 KB Q2 2021 Presentation 1.2 MB Q2 2021 Supplementary Info 209.8 KB Q2 2021 Summary of Remarks 606.7 KB Q2 2021 Prepared Remarks 250.7 KB Q2 2021 10-Q 617.9 KB Jun 9, 2021 at 2:10 PM EDT Gilead Sciences at Goldman Sachs Annual Global Healthcare Conference Jun 2, 2021 at 4:30 PM EDT Gilead Sciences at Bernstein Annual Strategic Decisions Conference View All
